Forthe staging of prostate carcinoma, recent studies have shown that68Ga-PSMA PET/CT has considerable potential, as does as PSMA-PET/CT withother radiotracers, especially in patients with intermediateor high-risk disease, aswell as in those with negative findings, inconclusive findings, or oligometastaticdisease on conventional imaging examinations(6). Here, FOLH1 is linked to prostate carcinoma.